FindTrial
Sign In

A Phase 2 Study of TRK-130 in Patients With Overactive Bladder

A Phase 2 Study of TRK-130 in Patients With Overactive Bladder

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220843
Enrollment
Unknown
Registered
2009-09-04
Start date
2009-09-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

investigational material(s) Generic name etc : TRK-130 INN of investigational material : Therapeutic category code : 251 Agents affecting urinary organs Dosage and Administration for Investigational

Sponsors

Toray Industries,Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with a symptom of overactive bladder for more than 6 months

Exclusion criteria

Exclusion criteria: Patients with genius stress incontinence Patients with clinically significant outflow obstruction

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026